Annual D&A
$1.33M$1.18M-46.95%
Summary
- Current Value
- As of today, CLOV annual D&A is $1.33M, down -46.95% on
- Historical Performance
- CLOV annual D&A is up +6.82% over the past 3 years, and up +141.56% over the past 5 years
- All-Time High Comparison
- CLOV annual D&A is currently -46.95% below its historical high of $2.51M set on
- 3-Year Low Comparison
- CLOV annual D&A is +12.13% above its 3-year low of $1.19M reached on an earlier date
- Sector Comparison
- CLOV annual D&A is higher than 44.12% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $1.33M | -47.0% | +6.8% | +141.6% | +141.6% | |
| Quarterly D&A | $406.00K | +19.8% | -34.1% | +194.2% | – | |
| TTM D&A | $1.61M | -3.1% | -44.0% | +289.8% | – | |
| Price | $2.54 | -29.4% | +151.5% | -84.1% | – | |
| Annual SG&A | $408.93M | -7.1% | -8.3% | +118.3% | +118.3% | |
| Annual Total Expenses | $1.42B | -1.6% | -32.8% | +119.5% | +119.5% | |
| Annual Operating Expenses | $410.27M | -5.8% | -26.4% | +109.6% | +109.6% | |
| Annual Revenue | $1.37B | +9.2% | -10.9% | +100.0% | +100.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.51M | -47.0% | |
| 5Y | $2.51M | -47.0% | |
| All | $2.51M | -47.0% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.19M | N/A | +12.1% |
| 5Y | $555.00K | N/A | +139.8% |
| All | $551.00K | +141.6% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $1.33M | -47.0% | |
| $2.51M | +111.4% | |
| $1.19M | -4.7% |
| Year | Value | Change |
|---|---|---|
| $1.25M | +124.5% | |
| $555.00K | +0.7% | |
| $551.00K | - |
FAQ
What is the current annual D&A of CLOV?
As of today, CLOV annual D&A is $1.33M
What is 1-year change in CLOV annual D&A?
CLOV annual D&A is down -46.95% year-over-year
What is 3-year change in CLOV annual D&A?
CLOV annual D&A is up +6.82% over the past 3 years
How far is CLOV annual D&A from its all-time high?
CLOV annual D&A is currently -46.95% below its historical high of $2.51M set on December 31, 2023
How does CLOV annual D&A rank versus sector peers?
CLOV annual D&A is higher than 44.12% of companies in Healthcare sector
When is CLOV next annual earnings release?
The next annual earnings release for CLOV is on
Quarterly D&A
$406.00K$12.00K+3.05%
Summary
- Current Value
- As of today, CLOV quarterly D&A is $406.00K, up +3.05% on
- Historical Performance
- CLOV quarterly D&A is up +19.76% year-over-year, and down -34.09% over the past 3 years
- All-Time High Comparison
- CLOV quarterly D&A is currently -59.36% below its historical high of $999.00K set on
- 3-Year Low Comparison
- CLOV quarterly D&A is +148.28% above its 3-year low of -$841.00K reached on an earlier date
- Sector Comparison
- CLOV quarterly D&A is higher than 46.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $406.00K | +3.0% | +19.8% | -34.1% | +194.2% | |
| Annual D&A | $1.33M | – | -47.0% | +6.8% | +141.6% | |
| TTM D&A | $1.61M | +4.3% | -3.1% | -44.0% | +289.8% | |
| Price | $2.54 | -5.9% | -29.4% | +151.5% | -84.1% | |
| Quarterly SG&A | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Expenses | $503.51M | +3.1% | +48.2% | -45.9% | +146.4% | |
| Quarterly Operating Expenses | $41.90M | +296.1% | +349.4% | -44.2% | +258.5% | |
| Quarterly Revenue | $496.65M | +4.0% | +50.0% | -42.0% | +128.7% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $466.00K | -12.9% | |
| 3Y | $999.00K | -59.4% | |
| 5Y | $999.00K | -59.4% | |
| All | $999.00K | -59.4% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $344.00K | N/A | +18.0% |
| 3Y | -$841.00K | N/A | +148.3% |
| 5Y | -$841.00K | +148.3% | |
| All | -$841.00K | +148.3% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of CLOV?
As of today, CLOV quarterly D&A is $406.00K
What is CLOV quarterly D&A most recent change?
CLOV quarterly D&A was up +3.05% on September 30, 2025
What is 1-year change in CLOV quarterly D&A?
CLOV quarterly D&A is up +19.76% year-over-year
How far is CLOV quarterly D&A from its all-time high?
CLOV quarterly D&A is currently -59.36% below its historical high of $999.00K set on June 30, 2023
How does CLOV quarterly D&A rank versus sector peers?
CLOV quarterly D&A is higher than 46.30% of companies in Healthcare sector
When is CLOV next earnings release?
The next earnings release for CLOV is on
TTM D&A
$1.61M$67.00K+4.34%
Summary
- Current Value
- As of today, CLOV TTM D&A is $1.61M, up +4.34% on
- Historical Performance
- CLOV TTM D&A is down -3.07% year-over-year, and down -44.02% over the past 3 years
- All-Time High Comparison
- CLOV TTM D&A is currently -44.02% below its historical high of $2.88M set on
- 3-Year Low Comparison
- CLOV TTM D&A is +151.56% above its 3-year low of $640.00K reached on
- Sector Comparison
- CLOV TTM D&A is higher than 45.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $1.61M | +4.3% | -3.1% | -44.0% | +289.8% | |
| Annual D&A | $1.33M | – | -47.0% | +6.8% | +141.6% | |
| Quarterly D&A | $406.00K | +3.0% | +19.8% | -34.1% | +194.2% | |
| Price | $2.54 | -5.9% | -29.4% | +151.5% | -84.1% | |
| TTM SG&A | -$8.86B | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM Revenue | $1.77B | +10.3% | +32.2% | -41.3% | +215.4% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.61M | at high | |
| 3Y | $2.55M | -36.8% | |
| 5Y | $2.88M | -44.0% | |
| All | $2.88M | -44.0% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.33M | N/A | +21.0% |
| 3Y | $640.00K | +151.6% | |
| 5Y | $540.00K | +198.2% | |
| All | $122.00K | +1219.7% |
TTM D&A History
FAQ
What is the current TTM D&A of CLOV?
As of today, CLOV TTM D&A is $1.61M
What is CLOV TTM D&A most recent change?
CLOV TTM D&A was up +4.34% on September 30, 2025
What is 1-year change in CLOV TTM D&A?
CLOV TTM D&A is down -3.07% year-over-year
How far is CLOV TTM D&A from its all-time high?
CLOV TTM D&A is currently -44.02% below its historical high of $2.88M set on September 30, 2022
How does CLOV TTM D&A rank versus sector peers?
CLOV TTM D&A is higher than 45.53% of companies in Healthcare sector
When is CLOV next earnings release?
The next earnings release for CLOV is on
Data Sources & References
- CLOV Official Website www.cloverhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1801170/000180117025000269/0001801170-25-000269-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1801170/000180117025000052/0001801170-25-000052-index.htm
- CLOV Profile on Yahoo Finance finance.yahoo.com/quote/CLOV
- CLOV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clov